Showing 1 - 9 of 9
News, Apinya Wipatayotin, Published on 28/04/2020
» The Government Pharmaceutical Organisation (GPO) is working to make its own Favipiravir -- the antiviral medicine which has been touted as a treatment for Covid-19.
News, Apinya Wipatayotin, Published on 13/10/2019
» Three years after the passing of His Majesty King Bhumibol Adulyadej The Great, one of his legacies, artificial rainmaking, remains a solution that Thailand can depend on to tackle the problem of air pollution and climate change-induced drought.
News, Apinya Wipatayotin, Published on 27/06/2019
» The Thailand Science and Research Innovation (TSRI) on Wednesday gave awards to 13 research and innovation projects, among them a shirt that can tell a person's health condition from body smell, and a computer 3-D model that can help restore historic sites.
News, Apinya Wipatayotin, Published on 28/02/2019
» The country's first legal marijuana plantation was unveiled on Wednesday, amid intense public interest as Thailand embraces pot as a medical choice.
News, Apinya Wipatayotin, Published on 23/02/2019
» An amnesty proposal for marijuana possession is expected to be published in the Royal Gazette next week, according to Tharet Karatnaiyarawiwong, secretary-general of the Food and Drug Administration (FDA).
News, Apinya Wipatayotin, Published on 07/01/2019
» The name of Biothai, a non-governmental organisation, usually comes up when there are cases of foreign companies trying to patent traditional plants and their extracts.
News, Apinya Wipatayotin, Published on 28/11/2018
» FTA Watch, a non-governmental body monitoring free trade agreements, has expressed its disapproval of the regime's plan to invoke Section 44 to deal with contentious issues surrounding requests to patent marijuana extracts.
News, Apinya Wipatayotin, Published on 15/11/2018
» A group of local activists on Wednesday urged the Department of Intellectual Property to withdraw drug patent requests for cannabis extract.
News, Apinya Wipatayotin, Published on 03/11/2018
» The World Health Organisation (WHO) has certified the Government Pharmaceutical Organization’s (GPO) to produce the antiretroviral drug Efavirenz, in a move likely to reduce the cost of the drug in the region.